Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment.

SETTING Randomised controlled trial of latent tuberculosis infection (LTBI) treatment in 10 clinics in Canada, Saudi Arabia and Brazil. OBJECTIVE To identify early predictors of LTBI treatment adherence, including pre-treatment characteristics. DESIGN Patients randomised to 4 months of rifampicin (RMP; n = 420) or 9 months of isoniazid (n = 427) were… CONTINUE READING